- Home
- HBNC vs STAA Comparison
HBNC vs STAA Comparison
Compare HBNC & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBNC | STAA |
|---|---|---|
| Founded | 1873 | 1982 |
| Country | United States | United States |
| Employees | 491 | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.0M | 867.9M |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | HBNC | STAA |
|---|---|---|
| Price | $18.50 | $26.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $21.00 | ★ $22.81 |
| AVG Volume (30 Days) | 252.5K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | $5.52 | $8.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.38 | $15.59 |
| 52 Week High | $19.07 | $30.81 |
Technical Indicators
Market Signals| Indicator | HBNC | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 61.78 |
| Support Level | $15.69 | $26.54 |
| Resistance Level | $18.72 | $27.27 |
| Average True Range (ATR) | 0.49 | 1.07 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 83.85 | 63.16 |
Price Performance
Historical ComparisonAbout HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.